Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor

Author： Boumber Yanis Younes Anas Garcia-Manero Guillermo

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.6, 2011-06, pp. : 823-829

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Promising antitumor activity with MGCD0103, a novel isotype-selective histone deacetylase inhibitor

By Tourneau Christophe Le Siu Lillian L

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 8, 2008-08 ,pp. : 1247-1254

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: A Review on Class-I Specific Inhibition

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 9, 2015-07 ,pp. : 731-750

Bentham Science Publishers

Access to resources Recommend Favorite

MGCD 0103 active against recurrent lymphomas

Inpharma, Vol. 1, Iss. 1618, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

US orphan drug designation granted for MGCD0103

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Effect of a Histone Deacetylase Inhibitor on Human Cardiac Mass

By Shizukuda Yukitaka Piekarz Richard Bates Susan Sachdev Vandana Finkel Toren Rosing Douglas

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 1, 2005-01 ,pp. : 89-90

Springer Publishing Company

Access to resources Recommend Favorite